drugset

drugset / Trial / NCT06695572

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers

NCT06695572 ↗

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical Bumin Hospital · collab

RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, single dose, crossover study to evaluate the food effect of CKD-383 in healthy volunteers

Timeline

Start: 2024-11-06
Primary completion: 2024-12-07
Completion: 2024-12-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-383	Unknown	—	Oral

Indications